JP2016509059A5 - - Google Patents

Download PDF

Info

Publication number
JP2016509059A5
JP2016509059A5 JP2015558954A JP2015558954A JP2016509059A5 JP 2016509059 A5 JP2016509059 A5 JP 2016509059A5 JP 2015558954 A JP2015558954 A JP 2015558954A JP 2015558954 A JP2015558954 A JP 2015558954A JP 2016509059 A5 JP2016509059 A5 JP 2016509059A5
Authority
JP
Japan
Prior art keywords
composition
glycerophosphate
enteric coating
core
effective amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
JP2015558954A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016509059A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/017408 external-priority patent/WO2014130678A2/en
Publication of JP2016509059A publication Critical patent/JP2016509059A/ja
Publication of JP2016509059A5 publication Critical patent/JP2016509059A5/ja
Abandoned legal-status Critical Current

Links

JP2015558954A 2013-02-20 2014-02-20 腸管損傷および密着結合の機能不全に関連する疾患の治療および予防のための方法および組成物 Abandoned JP2016509059A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361766976P 2013-02-20 2013-02-20
US61/766,976 2013-02-20
US201361827080P 2013-05-24 2013-05-24
US61/827,080 2013-05-24
US201361897672P 2013-10-30 2013-10-30
US61/897,672 2013-10-30
PCT/US2014/017408 WO2014130678A2 (en) 2013-02-20 2014-02-20 Methods and compositions of treating and preventing intestinal injury and diseases related to tight junction dysfunction

Publications (2)

Publication Number Publication Date
JP2016509059A JP2016509059A (ja) 2016-03-24
JP2016509059A5 true JP2016509059A5 (https=) 2017-03-23

Family

ID=50240015

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015558954A Abandoned JP2016509059A (ja) 2013-02-20 2014-02-20 腸管損傷および密着結合の機能不全に関連する疾患の治療および予防のための方法および組成物

Country Status (9)

Country Link
US (1) US20150374725A1 (https=)
EP (1) EP2958567A2 (https=)
JP (1) JP2016509059A (https=)
KR (1) KR20150141943A (https=)
CN (1) CN105163740A (https=)
AU (1) AU2014218903A1 (https=)
HK (1) HK1219868A1 (https=)
MX (1) MX2015010765A (https=)
WO (1) WO2014130678A2 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR101476A1 (es) 2014-08-07 2016-12-21 Acerta Pharma Bv Métodos para tratar cánceres, enfermedades inmunes y autoinmunes, y enfermedades inflamatorias en base a la tasa de ocupación de la tirosin quinasa de bruton (btk) y a la tasa de resíntesis de la tirosin quinasa de bruton (btk)
EP3345591A1 (en) * 2017-01-06 2018-07-11 Oystershell NV Oral dosage form for enhanced solubilization of a poorly soluble active agent and method of preparation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2993837A (en) * 1959-07-13 1961-07-25 Frosst & Co Charles E Enteric coated tablets
US5665415A (en) 1995-07-26 1997-09-09 Akpharma Inc. Composition and method for increasing the pH of acid foods
US20020099037A1 (en) * 2001-01-19 2002-07-25 Akpharma, Inc. Method for alleviating syndromes and conditions of discomfort of the mammalian intestinal and genito-urinary tracts
US7402323B2 (en) 2002-08-21 2008-07-22 Akpharma, Inc. Compositions and methods for treating skin conditions
US20070155664A1 (en) * 2003-07-04 2007-07-05 Nycomed Danmark A/S Parathyroid hormone (pth) containing pharmaceutical compositions for oral use
AR045068A1 (es) * 2003-07-23 2005-10-12 Univ Missouri Formulacion de liberacion inmediata de composiciones farmaceuticas
WO2008100980A1 (en) * 2007-02-14 2008-08-21 Prelief Inc. Methods for treating or preventing inflammation using a glycerophosphate salt
US20080220084A1 (en) * 2007-03-09 2008-09-11 Pfantastic Medical Research Institute, Llc Combination therapy for alleviating pain-related conditions
EP2180895A4 (en) * 2007-08-30 2012-04-11 Prelief Inc METHODS FOR IMPROVING THE HEALING OF ORAL INJURY USING GLYCEROPHOSPHATE SALT
WO2009052489A2 (en) * 2007-10-19 2009-04-23 Alba Therapeutics Corporation Novel inhibitors of mammalian tight junction opening

Similar Documents

Publication Publication Date Title
JP2019526543A5 (https=)
AR122580A2 (es) Forma de dosificación de doxilamina y piridoxina y/o sus metabolitos o sales
EP2696679A4 (en) 2'-CYAN SUBSTITUTED NUCLEOSIDE DERIVATIVES AND METHOD FOR THEIR USE FOR THE TREATMENT OF VIRUS DISEASES
RU2018145985A (ru) Антагонисты активина-actrii и их применение для лечения нарушений костной ткани и других нарушений
AR128816A2 (es) Formas de dosificación farmacéutica de perlas de cisteamina
EP2827856A4 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF MUSCLE DISEASES
PL3405215T3 (pl) Sposoby leczenia choroby danona i innych zaburzeń autofagii
JP2014530840A5 (https=)
EP2956149A4 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI
EP2978446A4 (en) METHOD AND MEANS FOR THE TREATMENT OF MORBUS ALZHEIMER
MX2018006247A (es) Metodos para tratar la enfermedad de alzheimer y trastornos relacionados.
JP2016519107A5 (https=)
EP3849573A4 (en) BACTERIAL THERAPY AGAINST PROPRIONIBACTERIUM ACNES FOR THE TREATMENT OF ACNE
JP2015535291A5 (https=)
WO2014107730A3 (en) Use of fatty acid niacin conjugates for treating diseases
IL280083A (en) A pharmaceutical dosage form that can be administered orally and with a modified release
EP3316874A4 (en) TOPICAL AND INJECTABLE RESIQUIMOD COMPOSITIONS FOR THE TREATMENT OF NEOPLASTIC GUM DISEASES
MA43758A (fr) Procédés pour déterminer le dosage d'un agent thérapeutique et traitements associés
MX2020003031A (es) Metodo para preparar una forma de dosificacion solida que comprende anticuerpos por granulacion humeda, extrusion y esferonizacion.
EP3373922A4 (en) COMPOSITIONS AND METHODS FOR TREATING HOMOCYSTINURIA
JP2016509059A5 (https=)
HUE042932T2 (hu) Koleszterinészter-transzferprotein (CETP) inhibitor és az említett inhibitort tartalmazó gyógyászati készítmény szív- és érrendszeri betegségek kezelésében vagy megelõzésében való alkalmazásra
EP2877095A4 (en) IMAGING METHOD AND THERAPEUTIC METHOD FOR THE TREATMENT OF SUB-DAY TREATMENT DUMORS
JP2015516452A5 (https=)
EP3302529A4 (en) COMPOSITIONS AND METHODS FOR TREATING GALLENA GANGATRESIA IN NEWBORNS